AR094275A1 - COMPOSICION INMUNOGENICA QUE COMPRENDE LA PROTEINA CDTb DE CLOSTRIDIUM DIFFICILE - Google Patents
COMPOSICION INMUNOGENICA QUE COMPRENDE LA PROTEINA CDTb DE CLOSTRIDIUM DIFFICILEInfo
- Publication number
- AR094275A1 AR094275A1 ARP130105022A ARP130105022A AR094275A1 AR 094275 A1 AR094275 A1 AR 094275A1 AR P130105022 A ARP130105022 A AR P130105022A AR P130105022 A ARP130105022 A AR P130105022A AR 094275 A1 AR094275 A1 AR 094275A1
- Authority
- AR
- Argentina
- Prior art keywords
- seq
- protein
- clostridium difficile
- isolated
- cdtb
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 9
- 102000004169 proteins and genes Human genes 0.000 title abstract 9
- 239000000203 mixture Substances 0.000 title abstract 5
- 241000193163 Clostridioides difficile Species 0.000 title abstract 3
- 230000002163 immunogen Effects 0.000 title abstract 3
- 108010010925 Clostridium actin-specific ADP-ribosyltransferase Proteins 0.000 abstract 4
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 108700012359 toxins Proteins 0.000 abstract 2
- 108010042653 IgA receptor Proteins 0.000 abstract 1
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1223342.5A GB201223342D0 (en) | 2012-12-23 | 2012-12-23 | Immunogenic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR094275A1 true AR094275A1 (es) | 2015-07-22 |
Family
ID=47682553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130105022A AR094275A1 (es) | 2012-12-23 | 2013-12-20 | COMPOSICION INMUNOGENICA QUE COMPRENDE LA PROTEINA CDTb DE CLOSTRIDIUM DIFFICILE |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9669083B2 (enExample) |
| EP (1) | EP2934579B1 (enExample) |
| JP (1) | JP6515036B2 (enExample) |
| CN (1) | CN105120892B (enExample) |
| AR (1) | AR094275A1 (enExample) |
| AU (1) | AU2013366450A1 (enExample) |
| BR (1) | BR112015014727B8 (enExample) |
| CA (1) | CA2894951C (enExample) |
| ES (1) | ES2748054T3 (enExample) |
| GB (1) | GB201223342D0 (enExample) |
| SG (1) | SG11201504701UA (enExample) |
| WO (1) | WO2014096393A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103957931B (zh) | 2010-09-03 | 2017-10-24 | 瓦尔内瓦奥地利有限责任公司 | 艰难梭状芽胞杆菌毒素a和毒素b蛋白的分离多肽及其用途 |
| CN103619871B (zh) | 2011-04-22 | 2016-12-14 | 惠氏有限责任公司 | 涉及突变体难辨梭菌毒素的组合物及其方法 |
| KR20140101835A (ko) * | 2011-12-08 | 2014-08-20 | 노파르티스 아게 | 클로스트리듐 디피실레 톡신-기반 백신 |
| BR122016023101B1 (pt) * | 2012-10-21 | 2022-03-22 | Pfizer Inc | Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile |
| WO2015197737A1 (en) * | 2014-06-25 | 2015-12-30 | Glaxosmithkline Biologicals S.A. | Clostridium difficile immunogenic composition |
| WO2018170238A2 (en) * | 2017-03-15 | 2018-09-20 | Novavax, Inc. | Methods and compositions for inducing immune responses against clostridium difficile |
| US10933126B2 (en) | 2018-05-03 | 2021-03-02 | The Board Of Regents Of The University Of Oklahoma | Clostridium difficile immunogenic compositions and methods of use |
| BR112020024514A2 (pt) | 2018-06-19 | 2021-03-02 | Glaxosmithkline Biologicals S.A. | composição imunogênica |
| CN111793130B (zh) * | 2019-03-20 | 2021-09-14 | 华中农业大学 | 一株副猪嗜血杆菌CdtB杂交瘤细胞及单克隆抗体应用 |
| WO2021022033A1 (en) | 2019-07-30 | 2021-02-04 | Leung Kai P | Layered composite for scar treatment and prevention |
| WO2021255690A2 (en) | 2020-06-19 | 2021-12-23 | Pfizer Inc. | Immunogenic compositions against clostridioides (clostridium) difficile and methods thereof |
| GB202205833D0 (en) | 2022-04-21 | 2022-06-08 | Glaxosmithkline Biologicals Sa | Bacteriophage |
| WO2025029561A2 (en) * | 2023-07-28 | 2025-02-06 | University Of South Florida | Vaccine containing rbd2 of cdtb component from binary toxin cdt of clostridioides difficile |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2752033C (en) * | 2009-02-11 | 2020-03-24 | Cedars-Sinai Medical Center | Antibody to cytolethal distending toxin of campylobacter jejuni |
| US10046040B2 (en) | 2009-11-16 | 2018-08-14 | University Of Maryland, Baltimore | Multivalent live vector vaccine against Clostridium difficile-associated disease |
| CN103957931B (zh) * | 2010-09-03 | 2017-10-24 | 瓦尔内瓦奥地利有限责任公司 | 艰难梭状芽胞杆菌毒素a和毒素b蛋白的分离多肽及其用途 |
| AR089797A1 (es) | 2012-01-27 | 2014-09-17 | Merck Sharp & Dohme | Vacunas contra clostridum difficile que comprenden toxinas recombinantes |
-
2012
- 2012-12-23 GB GBGB1223342.5A patent/GB201223342D0/en not_active Ceased
-
2013
- 2013-12-20 JP JP2015548649A patent/JP6515036B2/ja not_active Expired - Fee Related
- 2013-12-20 WO PCT/EP2013/077762 patent/WO2014096393A1/en not_active Ceased
- 2013-12-20 BR BR112015014727A patent/BR112015014727B8/pt not_active IP Right Cessation
- 2013-12-20 CN CN201380073503.5A patent/CN105120892B/zh active Active
- 2013-12-20 AR ARP130105022A patent/AR094275A1/es unknown
- 2013-12-20 CA CA2894951A patent/CA2894951C/en active Active
- 2013-12-20 ES ES13817931T patent/ES2748054T3/es active Active
- 2013-12-20 EP EP13817931.2A patent/EP2934579B1/en active Active
- 2013-12-20 AU AU2013366450A patent/AU2013366450A1/en not_active Abandoned
- 2013-12-20 US US14/653,989 patent/US9669083B2/en active Active
- 2013-12-20 SG SG11201504701UA patent/SG11201504701UA/en unknown
-
2017
- 2017-05-15 US US15/595,651 patent/US20180043005A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201504701UA (en) | 2015-07-30 |
| GB201223342D0 (en) | 2013-02-06 |
| BR112015014727B1 (pt) | 2022-08-02 |
| CN105120892A (zh) | 2015-12-02 |
| CA2894951A1 (en) | 2014-06-26 |
| BR112015014727B8 (pt) | 2022-09-20 |
| CA2894951C (en) | 2023-05-09 |
| BR112015014727A2 (pt) | 2017-10-10 |
| WO2014096393A1 (en) | 2014-06-26 |
| US20150313985A1 (en) | 2015-11-05 |
| JP6515036B2 (ja) | 2019-05-15 |
| US20180043005A1 (en) | 2018-02-15 |
| AU2013366450A1 (en) | 2015-07-23 |
| EP2934579A1 (en) | 2015-10-28 |
| CN105120892B (zh) | 2020-07-31 |
| JP2016504993A (ja) | 2016-02-18 |
| EP2934579B1 (en) | 2019-08-07 |
| ES2748054T3 (es) | 2020-03-12 |
| US9669083B2 (en) | 2017-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR094275A1 (es) | COMPOSICION INMUNOGENICA QUE COMPRENDE LA PROTEINA CDTb DE CLOSTRIDIUM DIFFICILE | |
| CY1119916T1 (el) | Ανοσογονικη συνθεση | |
| AR091069A1 (es) | Proteinas de union a antigeno dirigidas contra el receptor st2 | |
| PE20120532A1 (es) | ANTICUERPOS ANTI-ActRIIB | |
| BR112019023071A2 (pt) | proteínas de fusão do receptor tgf-beta do tipo ii e uso das mesmas | |
| PE20191551A1 (es) | Polipeptidos de union al receptor de transferrina disenados | |
| IN2014DN03451A (enExample) | ||
| MX2021006017A (es) | Polipeptidos de folistatina y sus usos. | |
| UY40283A (es) | Método para alterar una propiedad de una planta | |
| MX2015000397A (es) | Complejo del factor viii con xten y proteina del factor von willebrand, y sus usos. | |
| MX361076B (es) | Proteínas multifunción que comprenden complejo mayor de histocompatibilidad (cmh) de clase i multivalente unido mediante disulfuro. | |
| MX2016004579A (es) | Proteinas de union del miembro 1 de la familia de transmembrana 4 l-seis (tm4sf1) y metodos de uso de las mismas. | |
| WO2013184938A3 (en) | Fusion polypeptides comprising mucin-domain polypeptide linkers | |
| MX2016008355A (es) | Anticuerpos que comprenden extensiones de polipeptidos de cadena ligera en el extremo c y conjugados y metodos de uso de estos. | |
| MX2021000030A (es) | Metodos y composiciones que utilizan polipeptidos variantes klotho. | |
| BR112018012694A2 (pt) | composição de célula dendrítica, vacina de célula dendrítica, composição e kit | |
| WO2008124646A3 (en) | Use of amyloid proteins as vaccine scaffolds | |
| EA201491277A1 (ru) | Противораковый слитый белок | |
| IN2014DN08325A (enExample) | ||
| CL2011002994A1 (es) | Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal. | |
| NZ702285A (en) | Staphylococcal coagulase antigens and methods of their use | |
| MX365560B (es) | Proteinas quimericas basadas en cyaa que comprenden un polipeptido heterologo y sus usos en la induccion de respuestas inmunes. | |
| BR112012013581A8 (pt) | vacinas de malária baseadas em ferlinas apicomplexas, proteínas semelhantes a ferlinas e outras proteínas que contêm o domínio c2 | |
| MX374380B (es) | Composicion inmunógena de clostridium difficile. | |
| AR082160A1 (es) | Anticuerpos monoclonales dirigidos contra la toxina tetanica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |